Thanks to visit codestin.com
Credit goes to www.scribd.com

0% found this document useful (0 votes)
4 views25 pages

Algorithm

This document outlines treatment algorithms for managing arrhythmias leading to cardiac arrest, specifically focusing on Ventricular Fibrillation, Pulseless Ventricular Tachycardia, Pulseless Electrical Activity, and Asystole. It emphasizes the importance of high-quality CPR, early recognition of arrhythmias, and addressing reversible causes. Additionally, it provides algorithms for tachycardia and bradycardia management, including drug administration and cardioversion techniques.

Uploaded by

faizaiman92
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
4 views25 pages

Algorithm

This document outlines treatment algorithms for managing arrhythmias leading to cardiac arrest, specifically focusing on Ventricular Fibrillation, Pulseless Ventricular Tachycardia, Pulseless Electrical Activity, and Asystole. It emphasizes the importance of high-quality CPR, early recognition of arrhythmias, and addressing reversible causes. Additionally, it provides algorithms for tachycardia and bradycardia management, including drug administration and cardioversion techniques.

Uploaded by

faizaiman92
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd
You are on page 1/ 25

ARRHYTHMIA

TREATMENT
ALGORITHMS

NCORT, ALS SUBCOMMITTEE 2021


1
Objectives

Upon completion of this session, you will be able to :


 List the four arrhythmias leading to cardiac arrest
 State the treatment algorithms for VF/ pulseless
VT (pVT), PEA and Asystole
 Understand the principles of management of
tachy and brady arrythmias

NCORT, ALS SubCommittee 2021 2


Cardiac Arrest

Occurs with one of four arrhythmias:

 Ventricular fibrillation (VF)


 Pulseless ventricular tachycardia (pVT)
 Pulseless electrical activity (PEA)
 Asystole

NCORT, ALS SubCommittee 2021 3


NCORT, ALS SubCommittee 2021 4
Cardiac Arrest Algorithm.. cont..

Return of
High Quality CPR Shock Energy Drug Advanced Airway Spontaneous Reversible Causes
for Defibrillation therapy Circulation
(ROSC)
• Push hard(at least 5cm) Biphasic Adrenaline • Endotracheal • Pulse present 5Hs
and fast(at least 100- Manufacturer IV/IO dose1 mg intubation or and blood • Hypovolemia
120/min) and allow recommendation every 3-5 supraglottic pressure • Hypoxia
complete chest recoil (eg initial dose of minutes advanced airway recordable • Hydrogen ion
• Minimise interruptions 120-200J); If • Waveform (acidosis)
in compression unknown, use Amiodarone capnography or • Abrupt and • Hypo/ hyperkalaemia
• Avoid excessive maximum available. IV/IO dose capnometry to sustained • Hypothermia
ventilation Second and First dose confirm and monitor increase in
• Change compressor subsequent doses 300mg bolus ETT placement ETCO2 5Ts
every 2 min or sooner should be Second dose • Once advanced • Tension
if fatigued equivalent, and 150mg airway in place, give • Spontaneous pneumothorax
• If no advanced airway, higher doses may Or 1 breath every 6 arterial • Tamponade, cardiac
30:2 compression: be considered Lignocaine seconds pressure • Toxins
ventilation ratio or 1 IV/IO dose • (10 breaths/minute) waves with • Thrombosis,
breath every 6 seconds Monophasic First dose 1- with continuous intra-arterial pulmonary
• Qualitative waveform 360J 1.5mg/kg chest compressions monitoring • Thrombosis,
capnography – if ETCO2 coronary
is low or decreasing, Second dose
reassess CPR quality 0.5-0.75mg/kg

NCORT, ALS SubCommittee 2021 5


Causes: 5H’s and 5T’s

• Hypoxia
• Hypokalemia/hyperkalemia
• Hypothermia
• Hypovolaemia
• Hydrogen ions (acidosis)

NCORT, ALS SubCommittee 2021 6


Causes: H’s and T’s ….cont

• Tamponade (cardiac)
• Thrombosis (pulmonary)
• Thrombosis (coronary)
• Toxins
• Tension pneumothorax

NCORT, ALS SubCommittee 2021 7


What is this rhythm?

NCORT, ALS SubCommittee 2021 8


What is this rhythm?

NCORT, ALS SubCommittee 2021 9


What is this rhythm?

NCORT, ALS SubCommittee 2021 10


ALS Subcommittee
2010
What is this rhythm?

NCORT, ALS SubCommittee 2021 11


ALS Subcommittee
2010
What is this rhythm?

NCORT, ALS SubCommittee 2021 12


Cardiac Tamponade

• Chest x-ray
• Widened mediastinum
• Pneumo- or
haemothorax
• Electrical alternans

• Note rounded bottle shape


to left side of heart
NCORT, ALS SubCommittee 2021 13
Tension Pneumothorax

A: Air under
A tension in
left thorax

Pleural margin;
partial lung
collapse

Left
Right

NCORT, ALS SubCommittee 2021


14
Asystole/PEA Algorithm

Adrenaline 1 mg IV push,
repeat every 3 to 5 minutes,

If Asystole persists
Withhold or cease resuscitation efforts?

• Consider quality of resuscitation?


• Atypical clinical features present?
• Search for DNR order

NCORT, ALS SubCommittee 2021 15


Tachy/bradyarrhythmias

Is patient stable or unstable?


Patient has serious signs or symptoms?
Chest pain (ischemic? possible ACS?)
Shortness of breath (lungs getting ‘wet’? possible CCF?)
Low blood pressure (orthostatic? dizzy? lightheaded?)
Decreased level of consciousness (poor cerebral perfusion?)
Clinical shock (cool and clammy? peripheral vasoconstriction?)

Are the signs and symptoms due to the slow or


rapid heart rate?
NCORT, ALS SubCommittee 2021 16
Bradycardia Algorithms

NCORT, ALS SubCommittee 2021 17


Adult
Bradycardia
Algorithm

NCORT, ALS SubCommittee 2021 18


Adult bradycardia algorithm..con’t

DRUGS
Atropine Aminophylline
First dose 0.5 mg IV bolus. Repeat every If beta blocker overdose, spinal cord
3 – 5 minutes. Maximum 3 mg injury or post heart transplant recipient
100 - 200 mg IV slow injection

Dopamine Glucagon
5 - 20 ug/kg/min IV infusion titrated to If calcium channel blocker or beta
patient response. Taper slowly blocker overdose 50 ug/kg IV loading
followed by 1-15 mg/hour infusion
Adrenaline 2 – 10 ug/min IV infusion titrated to patient response
titrated to patient response

NCORT, ALS SubCommittee 2021 19


Tachycardia Algorithms

NCORT, ALS SubCommittee 2021 20


212021
NCORT, ALS SubCommittee
Adult tachycardia..con’t..

NCORT, ALS SubCommittee 2021 22


Adult tachycardia with pulse
algorithm..con’t..
DRUGS
Adenosine
6mg rapid IV push followed with NS flush;
2nddose 12mg if required;
3rddose 18mg if required
Amiodarone
300 mg IV infusion over 10 -20 minutes
if unstable; over 60 minutes if stable
Consider IV infusion 900mg over 24 hours if
needed
Lignocaine
1-1.5 mg/kg IV bolus.
2nd dose 0.5 – 0.75 mg/kg if required
Magnesium
1 to 2 grams IV over 15 minutes, may be followed
by an infusion

NCORT, ALS SubCommittee 2021 23


Tachyarrhythmia
CARDIOVERSION
Synchronized cardioversion:
Refer to your device’s specific recommended
energy level to maximize first shock success
Recommended energy level:

Waveform Biphasic Monophasic


energy energy
Narrow regular 70 – 120J 100J
(SVT, atrial flutter)
Narrow irregular 120 – 150J 200J
(AF)
Broad complex
tachycardia (VT) 120 – 150J 200J

Monomorphic VT 120 – 150J 200J

NCORT, ALS SubCommittee 2021 24


Summary

• Effective ALS begins with high quality CPR


• Uninterrupted high quality chest compressions
improve outcome
– Rhythm check, rescue breath, even drug administration
should NOT interrupt compressions
• Early recognition & treatment of arrhythmias
give the best chance of survival
• Treat the underlying cause

NCORT, ALS SubCommittee 2021 25

You might also like